BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 27, 2019
View Archived Issues
Mouse model of 8-OH-DPAT-induced compulsive-like responses confirms the key role of 5-HT
Read More
EA-230 attenuates the systemic inflammatory response in humans
Read More
Chromatin problem linked to accelerated aging
Read More
CD40-targeting peptide KGYY-6 may ameliorate multiple sclerosis
Read More
Tuberculosis vaccine MTBVAC shows promise in phase I/II trial in adults and infants
Read More
New potent vanin-1 inhibitor as preclinical candidate for inflammatory bowel disease
Read More
FDA grants approval for Taltz as treatment of active ankylosing spondylitis
Read More
Positive topline results from pivotal phase III ORION-11 study of inclisiran
Read More
PACAP27 identified as a novel target for the treatment of migraine
Read More
IL-2-R336A fusion toxin enhances antitumor immune response in preclinical models
Read More
Esteve Pharmaceuticals describes dual CACNA2D1/mu opioid receptor ligands
Read More
New lysosomal acid glucosylceramidase inhibitors identified at Takeda
Read More
Heparegenix synthesizes new MAPKK 4 inhibitors
Read More
Janssen presents respiratory syncytial virus replication inhibitors
Read More
Ubiquitin carboxyl-terminal hydrolase 19 inhibitors discovered at Almac Discovery
Read More
Ivy, Salarius Pharmaceuticals enter collaboration to develop new cancer treatment for glioblastoma
Read More
DNA's sweet tooth linked to increased cancer risk with diabetes
Read More
Basilea completes enrollment in phase I study of oral BAL-101553 in brain cancer
Read More
New global phase IIa study evaluates tezepelumab for moderate to very severe COPD
Read More
Phase IIb CONDUCT study of cobitolimod in ulcerative colitis meets primary endpoint
Read More
ADC Therapeutics and Freenome enter biomarker collaboration for ADCT-402 program
Read More
CPRIT grant supports Emtora's development of eRapa for familial adenomatous polyposis
Read More